Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hypericum and depression

This article was originally published in The Tan Sheet

Executive Summary

St. John's wort constituent has "clinically significant effect on mild to moderately depressed nondysthymic patients," researchers at Frederiksberg Hospital, Denmark, conclude, cautioning "measures of depression are subject to large placebo effects requiring large groups of patients for comparative studies." In the study, 150 patients were randomized to receive placebo or 2,350 mg/day hypericum and were followed up at three and six weeks, C. Randlov and colleagues explain. The supplement was well tolerated and produced no serious adverse events, Randlov adds
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS092593

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel